Author:
Pols H. A. P.,Birkenhäger J. C.,Leeuwen J. P. T. M.
Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Reference89 articles.
1. Prevention of immunological disorders in MRL/1 mice by a new synthetic analogue of vitamin D3: 22-oxa-1α,25-dihydroxy-vitamin D3;Abe;Journal of Nutritional Science and Vitaminology,1990
2. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia;Abe;Endocrinology,1991
3. A synthetic analogue of vitamin D3, 22-oxa-1α,25-dihydroxyvitamin D3, is a potent modulator of in vivo immuno-regulating activity without inducing hypercalcemia in mice;Abe;Endocrinology,1989
4. Lysophosphatidylinositol: a potential mediator of 1,25-dihydroxyvitamin D3-induced increments in hepatocyte cytosolic calcium;Baran;Endocrinology,1988
5. 1,25-Dihydroxyvitamin D3 increases hepatocyte cytosolid calcium levels. A potential regulator of vitamin D-25-hydroxylase;Baran;Journal of Clinical Investigation,1986
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献